vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Rollins, Inc. is the larger business by last-quarter revenue ($906.4M vs $719.4M, roughly 1.3× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 11.9%, a 61.3% gap on every dollar of revenue. On growth, Rollins, Inc. posted the faster year-over-year revenue change (10.2% vs 3.1%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $111.2M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs 0.8%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

DOC vs ROL — Head-to-Head

Bigger by revenue
ROL
ROL
1.3× larger
ROL
$906.4M
$719.4M
DOC
Growing faster (revenue YoY)
ROL
ROL
+7.1% gap
ROL
10.2%
3.1%
DOC
Higher net margin
DOC
DOC
61.3% more per $
DOC
73.2%
11.9%
ROL
More free cash flow
DOC
DOC
$245.8M more FCF
DOC
$357.0M
$111.2M
ROL
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
0.8%
ROL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DOC
DOC
ROL
ROL
Revenue
$719.4M
$906.4M
Net Profit
$114.0M
$107.8M
Gross Margin
Operating Margin
17.4%
16.1%
Net Margin
73.2%
11.9%
Revenue YoY
3.1%
10.2%
Net Profit YoY
2406.4%
2.5%
EPS (diluted)
$0.16
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
ROL
ROL
Q1 26
$906.4M
Q4 25
$719.4M
$912.9M
Q3 25
$705.9M
$1.0B
Q2 25
$694.3M
$999.5M
Q1 25
$702.9M
$822.5M
Q4 24
$698.0M
$832.2M
Q3 24
$700.4M
$916.3M
Q2 24
$695.5M
$891.9M
Net Profit
DOC
DOC
ROL
ROL
Q1 26
$107.8M
Q4 25
$114.0M
$116.4M
Q3 25
$-117.1M
$163.5M
Q2 25
$31.7M
$141.5M
Q1 25
$42.8M
$105.2M
Q4 24
$4.5M
$105.7M
Q3 24
$85.9M
$136.9M
Q2 24
$146.0M
$129.4M
Gross Margin
DOC
DOC
ROL
ROL
Q1 26
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Operating Margin
DOC
DOC
ROL
ROL
Q1 26
16.1%
Q4 25
17.4%
17.5%
Q3 25
9.2%
21.9%
Q2 25
5.7%
19.8%
Q1 25
7.7%
17.3%
Q4 24
-2.2%
18.1%
Q3 24
14.1%
20.9%
Q2 24
22.3%
20.4%
Net Margin
DOC
DOC
ROL
ROL
Q1 26
11.9%
Q4 25
73.2%
12.8%
Q3 25
-16.6%
15.9%
Q2 25
4.6%
14.2%
Q1 25
6.1%
12.8%
Q4 24
0.7%
12.7%
Q3 24
12.3%
14.9%
Q2 24
21.0%
14.5%
EPS (diluted)
DOC
DOC
ROL
ROL
Q1 26
$0.22
Q4 25
$0.16
$0.24
Q3 25
$-0.17
$0.34
Q2 25
$0.05
$0.29
Q1 25
$0.06
$0.22
Q4 24
$0.02
$0.22
Q3 24
$0.12
$0.28
Q2 24
$0.21
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$467.5M
$116.5M
Total DebtLower is stronger
$9.8B
$650.6M
Stockholders' EquityBook value
$7.5B
$1.4B
Total Assets
$20.3B
$3.2B
Debt / EquityLower = less leverage
1.31×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
ROL
ROL
Q1 26
$116.5M
Q4 25
$467.5M
$100.0M
Q3 25
$91.0M
$127.4M
Q2 25
$89.4M
$123.0M
Q1 25
$70.6M
$201.2M
Q4 24
$119.8M
$89.6M
Q3 24
$180.4M
$95.3M
Q2 24
$106.9M
$106.7M
Total Debt
DOC
DOC
ROL
ROL
Q1 26
$650.6M
Q4 25
$9.8B
$486.1M
Q3 25
$9.1B
$485.7M
Q2 25
$9.0B
$485.3M
Q1 25
$8.9B
$485.5M
Q4 24
$8.7B
$395.3M
Q3 24
$8.6B
Q2 24
$8.6B
Stockholders' Equity
DOC
DOC
ROL
ROL
Q1 26
$1.4B
Q4 25
$7.5B
$1.4B
Q3 25
$7.6B
$1.5B
Q2 25
$7.9B
$1.4B
Q1 25
$8.2B
$1.4B
Q4 24
$8.4B
$1.3B
Q3 24
$8.6B
$1.3B
Q2 24
$8.8B
$1.2B
Total Assets
DOC
DOC
ROL
ROL
Q1 26
$3.2B
Q4 25
$20.3B
$3.1B
Q3 25
$19.6B
$3.2B
Q2 25
$19.8B
$3.2B
Q1 25
$19.8B
$2.9B
Q4 24
$19.9B
$2.8B
Q3 24
$20.0B
$2.8B
Q2 24
$20.2B
$2.8B
Debt / Equity
DOC
DOC
ROL
ROL
Q1 26
0.47×
Q4 25
1.31×
0.35×
Q3 25
1.20×
0.32×
Q2 25
1.14×
0.34×
Q1 25
1.08×
0.36×
Q4 24
1.04×
0.30×
Q3 24
1.00×
Q2 24
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
ROL
ROL
Operating Cash FlowLast quarter
$1.3B
$118.4M
Free Cash FlowOCF − Capex
$357.0M
$111.2M
FCF MarginFCF / Revenue
49.6%
12.3%
Capex IntensityCapex / Revenue
124.4%
0.8%
Cash ConversionOCF / Net Profit
10.99×
1.10×
TTM Free Cash FlowTrailing 4 quarters
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
ROL
ROL
Q1 26
$118.4M
Q4 25
$1.3B
$164.7M
Q3 25
$315.0M
$191.3M
Q2 25
$363.5M
$175.1M
Q1 25
$279.4M
$146.9M
Q4 24
$1.1B
$188.2M
Q3 24
$318.2M
$146.9M
Q2 24
$316.2M
$145.1M
Free Cash Flow
DOC
DOC
ROL
ROL
Q1 26
$111.2M
Q4 25
$357.0M
$159.0M
Q3 25
$182.8M
Q2 25
$168.0M
Q1 25
$140.1M
Q4 24
$333.7M
$184.0M
Q3 24
$139.4M
Q2 24
$136.4M
FCF Margin
DOC
DOC
ROL
ROL
Q1 26
12.3%
Q4 25
49.6%
17.4%
Q3 25
17.8%
Q2 25
16.8%
Q1 25
17.0%
Q4 24
47.8%
22.1%
Q3 24
15.2%
Q2 24
15.3%
Capex Intensity
DOC
DOC
ROL
ROL
Q1 26
0.8%
Q4 25
124.4%
0.6%
Q3 25
0.8%
Q2 25
0.7%
Q1 25
0.8%
Q4 24
105.6%
0.5%
Q3 24
0.8%
Q2 24
1.0%
Cash Conversion
DOC
DOC
ROL
ROL
Q1 26
1.10×
Q4 25
10.99×
1.41×
Q3 25
1.17×
Q2 25
11.48×
1.24×
Q1 25
6.52×
1.40×
Q4 24
235.43×
1.78×
Q3 24
3.71×
1.07×
Q2 24
2.17×
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons